Single dose versus multiple doses of rituximab for preemptive therapy of Epstein–Barr virus reactivation after hematopoietic cell transplantation
Leukemia & Lymphoma | July 6, 2018 | Volume: 60 | Issue: 1 | Pages: 110-117
10.1080/10428194.2018.1459603
| PMID 29979906